Browse > Article
http://dx.doi.org/10.15324/kjcls.2018.50.4.375

Overview of Cytogenetic Technologies  

Kang, Ji-Un (Department of Biomedical Laboratory Science, Korea Nazarene University)
Publication Information
Korean Journal of Clinical Laboratory Science / v.50, no.4, 2018 , pp. 375-381 More about this Journal
Abstract
Cytogenetic analysis plays an important role in examinations of a variety of human disorders. Over the years, cytogenetic analysis has evolved to a great extent and become a part of routine laboratory testing; the analysis provides significant diagnostic and prognostic results for human diseases. Microarray in conjunction with molecular cytogenetics and conventional chromosome analysis has transformed the outcomes of clinical cytogenetics. The advantages of microarray technologies have become obvious to the medical and laboratory community involved in genetic diagnosis, resulting in greatly improved visualization and validation capabilities. This article reviews how the field is moving away from conventional cytogenetics towards molecular approaches for the identification of pathogenic genomic imbalances and discusses practical considerations for the routine implementation of these technologies in genetic diagnosis.
Keywords
Conventional cytogenetics; Microarray technologies; Molecular cytogenetics;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Chandran RK, Geetha N, Sakthivel KM, Aswathy CG, Gopinath P, Raj TVA, et al. Genomic amplification of BCR-ABL1 fusion gene and its impact on the disease progression mechanism in patients with chronic myelogenous leukemia. Gene. 2018;686:85-91. https://doi.org/10.1016/j.gene.2018.11.005.
2 Krause FS, Rauch A, Schrott KM, Engehausen DG. Clinical decisions for treatment of different staged bladder cancer based on multitarget fluorescence in situ hybridization assays? World J Urol. 2006;24:418-422. https://doi.org/10.1007/s00345-006-0086-y.   DOI
3 Gullotta F, Biancolella M, Costa E, Colapietro I, Nardone AM, Molinaro P, et al. Prenatal diagnosis of genomic disorders and chromosome abnormalities using array-based comparative genomic hybridization. J Prenat Med. 2007;1:16-22.
4 Melissa SS, Mirella JM, Ronald JW. Evolving applications of microarray analysis in prenatal diagnosis. Curr Opin Obstet Gynecol. 2011;23:103-108. https://doi.org/10.1097/GCO.0b013e32834457c7.   DOI
5 Gresham D, Dunham MJ, Botstein D. Comparing whole genomes using DNA microarrays. Nat Rev Genet. 2008;9:291-302. https://doi.org/10.1038/nrg2335.   DOI
6 Kang J. Clinical implications of microarray in cancer medicine. International Journal of Cancer Research. 2015;11:150-158. https://doi.org/10.3923/ijcr.2015.150.158.   DOI
7 Wilch ES, Morton CC. Historical and clinical perspectives on chromosomal translocations. Adv Exp Med Biol. 2018;1044:1-14. https://doi.org/10.1007/978-981-13-0593-1_1.
8 Lin SY, Lee CN, Peng AY, Yuan TJ, Lee DJ, Lin WH, et al. Application of molecular cytogenetic techniques to characterize the aberrant Y chromosome arising de novo in a male fetus with mosaic 45,X and solve the discrepancy between karyotyping, chromosome microarray, and multiplex ligation dependent probe amplification. J Formos Med Assoc. 2018;117:1027-1031.   DOI
9 Speicher MR, Carter NP. The new cytogenetics: blurring the boundaries with molecular biology. Nat Rev Genet. 2005;6:782-792. https://doi.org/10.1038/nrg1692.   DOI
10 Li M, Pinkel D. Clinical cytogenetics and molecular cytogenetics. J Zhejiang Univ Sci B. 2006;7:162-163. https://doi.org/10.1631/jzus.2006.B0162.   DOI
11 Kang JU, Koo SH, Kwon KC, Park JW, Kim JM. Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2-q29 in squamous cell carcinoma of the lung. BMC Cancer. 2009;9:237. https://doi.org/10.1186/1471-2407-9-237.   DOI
12 Kriegsmann J, Kriegsmann M, Kriegsmann K, Longuespee R, Deininger SO, Casadonte R. MALDI imaging for proteomic painting of heterogeneous tissue structures. Proteomics Clin Appl. 2018:e1800045 https://doi.org/10.1002/prca.201800045.
13 Ebersole JL, Kirakodu S, Novak MJ, Orraca L, Stormberg AJ, Gonzalez-Martinez J, et al. Comparative analysis of expression of microbial sensing molecules in mucosal tissues with periodontal disease. Immunobiology. 2018;pii:S0171-2985(18)30197-9. https://doi.org/10.1016/j.imbio.2018.11.007.
14 Kang JU, Koo SH, Kwon KC, Park JW. Frequent silence of chromosome 9p, homozygous DOCK8, DMRT1 and DMRT3 deletion at 9p24.3 in squamous cell carcinoma of the lung. Int J Oncol. 2010;37:327-335.
15 Bacovsky V, Hobza R, Vyskot B. Technical review: cytogenetic tools for studying mitotic chromosomes. Methods Mol Biol. 2018;1675:509-535. https://doi.org/10.1007/978-1-4939-7318-7_30.
16 Manning M, Hudgins L. Professional Practice and Guidelines Committee. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med. 2010;12:742-745. https://doi.org/10.1097/GIM.0b013e3181f8baad.   DOI
17 Hochstenbach R, van Binsbergen E, Engelen J, Nieuwint A, Polstra A, Poddighe P, et al. Array analysis and karyotyping:workflow consequences based on a retrospective study of 36,325 patients with idiopathic developmental delay in the Netherlands. Eur J Med Genet. 2009;52:161-169. https://doi.org/10.1016/j.ejmg.2009.03.015.   DOI
18 Ma T, Huang C, Ni Y, Yang Y, Li J. ATP citrate lyase and LncRNA NONMMUT010685 play crucial role in nonalcoholic fatty liver disease based on analysis of microarray data. Cell Physiol Biochem. 2018;51:871-885. https://doi.org/10.1159/000495384.   DOI
19 Miller D T, Adam M P, Aradhya S, Biesecker LG, Brothman AR, Carter NP, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86: 749-764. https://doi.org/10.1016/j.ajhg.2010.04.006.   DOI
20 Peng R, Xie HN, Zheng J, Zhou Y, Lin MF. Fetal right aortic arch:associated anomalies, genetic anomalies with chromosomal microarray analysis, and postnatal outcome. Prenat Diagn. 2017;37:329-335. https://doi.org/10.1002/pd.5015.   DOI
21 Moeschler J B, Shevell M, Committee on Genetics. Comprehensive evaluation of the child with intellectual disability or global developmental delays. Pediatrics. 2014;134:903-918. https://doi.org/10.1542/peds.2014-1839.   DOI
22 Lichtenbelt KD, Knoers NV, Schuring-Blom GH. From karyotyping to array-CGH in prenatal diagnosis. Cytogenet Genome Res. 2011;135:241-250. https://doi.org/10.1159/000334065.   DOI
23 Shaffer LG, Coppinger J, Alliman S, Torchia BA, Theisen A, Ballif BC, et al. Comparison of microarray-based detection rates for cytogenetic abnormalities in prenatal and neonatal specimens. Prenat Diagn. 2008;28:789-795. https://doi.org/10.1002/pd.2053.   DOI
24 Oostlander AE, Meijer GA, Ylstra B. Microarray-based comparative genomic hybridization and its applications in human genetics. Clin Genet. 2004;66:488-495. https://doi.org/10.1111/j.1399-0004.2004.00322.x.   DOI
25 Herriges JC, Brown S, Longhurst M, Ozmore J, Moeschler JB, Janze A, et al. Identification of two 14q32 deletions involving DICER1 associated with the development of DICER1-related tumors. Eur J Med Genet. 2018;pii:S1769-7212(17)30841-8. https://doi.org/10.1016/j.ejmg.2018.04.011.
26 Pinto IP, Minasi LB, Steckelberg R, da Silva CC, da Cruz AD. Mosaic tetrasomy of 9p24.3q21.11 postnatally identified in an infant born with multiple congenital malformations: a case report. BMC Pediatr. 2018;18:298. https://doi.org/10.1186/s12887-018-1275-8.   DOI
27 Rego de Paula Junior M, Nonino A, Minuncio Nascimento J, Bonadio RS, Pic-Taylor A, de Oliveira SF, et al. High frequency of copy-neutral loss of heterozygosity in patients with myelofibrosis. Cytogenet Genome Res. 2018;154:62-70. https://doi.org/10.1159/000487627.   DOI
28 de Vries BB, Pfundt R, Leisink M, Koolen DA, Vissers LE, Janssen IM, et al. Diagnostic genome profiling in mental retardation. Am J Hum Genet. 2005;77:606-616. https://doi.org/10.1086/491719.   DOI
29 Vissers LE, de Vries BB, Osoegawa K, Janssen IM, Feuth T, Choy CO, et al. Array-based comparative genomic hybridization for the genomewide detection of submicroscopic chromosomal abnormalities. Am J Hum Genet. 2003;73:1261-1270. https://doi.org/10.1086/379977.   DOI
30 Sagoo GS, Butterworth AS, Sanderson S, Shaw-Smith C, Higgins JP, Burton H, et al. Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and metaanalysis of 19 studies and 13,926 subjects. Genet. 2009;11:139-146. https://doi.org/10.1097/GIM.0b013e318194ee8f.
31 George P, Wilhelm J, Phillip B. 3st ed. Molecular Diagnostics;2016. p249-267.
32 Kang JU, Koo SH. Evolving applications of microarray technology in postnatal diagnosis (review). Int J Mol Med. 2012;30:223-228. https://doi.org/10.3892/ijmm.2012.988.   DOI
33 Kang JU, Koo SH. Clinical implementation of chromosomal microarray technology in prenatal diagnosis (review). Mol Med Rep. 2012;6:1219-1222. https://doi.org/10.3892/mmr.2012.1116.   DOI
34 Nowakowska B, Bocian E. Molecular cytogenetic techniques and their application in clinical diagnosis. Med Wieku Rozwoj. 2004;8:7-24.
35 Simons A, Sikkema-Raddatz B, de Leeuw N, Konrad NC, Hastings RJ, Schoumans J. Genome-wide arrays in routine diagnostics of hematological malignancies. Hum Mutat. 2012;33:941-948. https://doi.org/10.1002/humu.22057.   DOI
36 Park JH, Woo JH, Shim SH, Yang SJ, Choi YM, Yang KS, et al. Application of a target array comparative genomic hybridization to prenatal diagnosis. BMC Med Genet. 2010;11:102. https://doi.org/10.1186/1471-2350-11-102.
37 Dave BJ, Sanger WG. Role of cytogenetics and molecular cytogenetics in the diagnosis of genetic imbalances. Semin Pediatr Neurol. 2007;14:2-6. https://doi.org/10.1016/j.spen.2006.11.003.   DOI
38 Chennamaneni R, Gundeti S, Konatam ML, Bala S, Kumar A, Srinivas L. Impact of cytogenetics on outcomes in pediatric acute lymphoblastic leukemia. South Asian J Cancer. 2018;7:263-266. https://doi.org/10.4103/sajc.sajc_13_18.   DOI
39 Vermeesch JR, Fiegler H, de Leeuw N, Szuhai K, Schoumans J, Ciccone R, et al. Guidelines for molecular karyotyping in constitutional genetic diagnosis. Eur J Hum Genet. 2007;15: 1105-1114. https://doi.org/10.1038/sj.ejhg.5201896.   DOI
40 Wan TS. Cancer cytogenetics: an introduction. Methods Mol Biol. 2017;1541:1-10. https://doi.org/10.1007/978-1-4939-6703-2_1.
41 Bejjani BA, Shaffer LG. Clinical utility of contemporary molecular cytogenetics. Annu Rev Genomics Hum Genet. 2008;9:71-86.   DOI
42 Chandran RK, Geetha N, Sakthivel KM, Aswathy CG, Gopinath P, Raj TVA, et al. Genomic amplification of BCR-ABL1 fusion gene and its impact on the disease progression mechanism in patients with chronic myelogenous leukemia. Gene. 2018;686:85-91. https://doi.org/10.1016/j.gene.2018.11.005.
43 Russo A, Degrassi F. Molecular cytogenetics of the micronucleus:Still surprising. Mutat Res. 2018;836(Pt A):36-40. https://doi.org/10.1016/j.mrgentox.2018.05.011.
44 Iourov IY, Vorsanova SG, Yurov YB. Recent patents on molecular cytogenetics. Recent Pat DNA Gene Seq. 2008;2:6-15.   DOI
45 Qiu HR, Miao KR, Wang R, Qiao C, Zhang JF, Zhang SJ, et al. The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2009;26:207-210. https://doi.org/10.3760/cma.j.issn.1003-9406.2009.02.020.
46 Shaffer LG, Bejjani BA. Medical applications of array CGH and the transformation of clinical cytogenetics. Cytogenet Genome Res. 2006;115:303-309. https://doi.org/10.1159/000095928.   DOI
47 Evangelidou P, Sismani C, Ioannides M, Christodoulou C, Koumbaris G, Kallikas I, et al. Clinical application of whole-genome array CGH during prenatal diagnosis: Study of 25 selected pregnancies with abnormal ultrasound findings or apparently balanced structural aberrations. Mol Cytogenet. 2010;3:24. https://doi.org/10.1186/1755-8166-3-24.   DOI
48 D'Amours G, Kibar Z, Mathonnet G, Fetni R, Tihy F, Desilets V, et al. Whole-genome array CGH identifies pathogenic copy number variations in fetuses with major malformations and a normal karyotype. Clin Genet. 2012;81:128-141. https://doi.org/10.1111/j.1399-0004.2011.01687.x.   DOI
49 Hillman SC, Pretlove S, Coomarasamy A, McMullan DJ, Davison EV, Maher ER, et al. Additional information from array comparative genomic hybridization technology over conventional karyotyping in prenatal diagnosis: a systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2011;37:6-14. https://doi.org/10.1002/uog.7754.   DOI
50 Li MM, Andersson HC. Clinical application of microarray-based molecular cytogenetics: an emerging new era of genomic medicine. J Pediatr. 2009;155:311-317. https://doi.org/10.1016/j.jpeds.2009.04.001.   DOI
51 Kang JU, Koo SH, Kwon KC, Park JW, Shin SY, Kim JM, et al. High frequency of genetic alterations in non-small cell lung cancer detected by multi-target fluorescence in situ hybridization. J Korean Med Sci. 2007;22:S47-S51. https://doi.org/10.3346/jkms.2007.22.S.S47.   DOI
52 Mohamed AM, El-Bassyouni HT, El-Gerzawy AM, Hammad SA, Helmy NA, Kamel AK, et al. Cytogenomic characterization of 1q43q44 deletion associated with 4q32.1q35.2 duplication and phenotype correlation. Mol Cytogenet. 2018;11:57. https://doi.org/10.1186/s13039-018-0406-0.   DOI